Cargando…
Atypical role of sprouty in colorectal cancer: sprouty repression inhibits epithelial–mesenchymal transition
Sprouty (SPRY) appears to act as a tumor suppressor in cancer, whereas we demonstrated that SPRY2 functions as a putative oncogene in colorectal cancer (CRC) (Oncogene, 2010, 29: 5241–5253). We investigated the mechanisms by which SPRY regulates epithelial–mesenchymal transition (EMT) in CRC. SPRY1...
Autores principales: | Zhang, Q, Wei, T, Shim, K, Wright, K, Xu, K, Palka-Hamblin, H L, Jurkevich, A, Khare, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4850112/ https://www.ncbi.nlm.nih.gov/pubmed/26434583 http://dx.doi.org/10.1038/onc.2015.365 |
Ejemplares similares
-
Erratum: Atypical role of sprouty in colorectal cancer: sprouty repression inhibits epithelial–mesenchymal transition
por: Zhang, Q, et al.
Publicado: (2017) -
Atypical role of sprouty in p21 dependent inhibition of cell proliferation in colorectal cancer
por: Zhang, Qiong, et al.
Publicado: (2015) -
Sprouty4 is epigenetically upregulated in human colorectal cancer
por: Stuckel, Alexei J., et al.
Publicado: (2022) -
Inducing Sprouty degradation
por: LeBrasseur, Nicole
Publicado: (2003) -
Sprouty3, but Not Sprouty1, Expression Is Beneficial for the Malignant Potential of Osteosarcoma Cells
por: Kamptner, Anna Zita Mehira, et al.
Publicado: (2021)